If Insmed DOES intend to go forward with Iplex imo the most likely reason for the delay would be that they have been establishing the most efficient delivery system now available.
With subcutaneous injection their hands are tied until January 2012. With an alternative delivery system there would be no part of the process in Europe NOW which would be covered by an unexpired Genentech patent.
And once on the shelves in Europe for Short Stature it could be purchased off-label for ALS, MMD etc.
How do you get away with deceiving for years? People keep on saying that you might ruin your credibility with each prediction but you're always wrong (deceiving). You've never had credibility as far as predictions go. I truly despise you and your stupid games.